Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
1.355
+0.025 (1.88%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Galectin Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
868110367123128
Upgrade
Market Cap Growth
-21.14%-21.14%52.89%-45.33%-3.92%-21.41%
Upgrade
Enterprise Value
1761611478410998
Upgrade
Last Close Price
1.341.291.661.132.072.24
Upgrade
PB Ratio
-0.82-0.79-1.70-2.0946.965.29
Upgrade
P/TBV Ratio
----335.625.83
Upgrade
Debt / Equity Ratio
-1.03-1.03-1.19-1.2411.110.00
Upgrade
Quick Ratio
0.430.431.641.434.395.03
Upgrade
Current Ratio
0.490.491.771.584.635.46
Upgrade
Return on Equity (ROE)
-----227.74%-67.25%
Upgrade
Return on Assets (ROA)
-116.08%-116.08%-96.17%-75.96%-52.81%-37.54%
Upgrade
Return on Capital (ROIC)
-359.82%-359.82%-246.50%-121.64%-67.46%-41.94%
Upgrade
Earnings Yield
-55.75%-58.11%-40.00%-57.74%-24.85%-18.35%
Upgrade
Buyback Yield / Dilution
-3.57%-3.57%-1.29%-1.48%-2.63%-9.17%
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q